awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55035103-452EB35C-4E3E-46B8-9FA5-385EC0150EED
Q55035103-452EB35C-4E3E-46B8-9FA5-385EC0150EED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55035103-452EB35C-4E3E-46B8-9FA5-385EC0150EED
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study.
P2860
Q55035103-452EB35C-4E3E-46B8-9FA5-385EC0150EED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55035103-452EB35C-4E3E-46B8-9FA5-385EC0150EED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
044246baa4a4476983dd27fccd2a6b5e9451b4a2
P2860
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.